ANAVEX LIFE SCIENCES CORP. — Form D
ANAVEX LIFE SCIENCES CORP. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2012-02-16. The offering totals $10K, of which $10K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-02-16
- Form: D
- Accession: 0001085037-12-000023
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $10K
- Amount sold: $10K
- Investors: 1
- Date of first sale: 2012-02-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-173543
Issuer
- Name: ANAVEX LIFE SCIENCES CORP.
- CIK: 0001314052
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 51 W 52ND STREET, NEW YORK, NY, 10019
- Phone: 844-689-3939
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| John Chisholm | Director | Boston, MA |
| Harvey Lalach | Director | Kelowna, A1 |
| Sean Lowry | Director | Toronto, A6 |
| GEORGE TIDMARSH | Director | SAN DIEGO, CA |
| Harvey Lalach | Executive Officer | Kelowna, A1 |
| GEORGE TIDMARSH | Executive Officer | SAN DIEGO, CA |
| Alexandre Vamvakides | Executive Officer | Paris, I0 |
| Cameron Durrant | Director | Lowell, MA |
| David Tousley | Director | Lenexa, KS |
| Christopher U Missling | Director | New York, NY |
| Christopher U Missling | Executive Officer | New York, NY |
| Athanosios U Skarpelos | Director | Athens J3, J3 |
| Alison Ayers | Director | West Orange, NJ |
Other filings by this issuer (3)
More